Patients
Physicians
Sponsors
Oncologists
About Us
News
ENG
Last updated 9 months ago
Share
A Study to Evaluate Higher Dose (HD) Nusinersen (BIIB058) in Participants With Spinal Muscular Atrophy Previously Treated With Risdiplam
45 patients around the world
Available in
United States, Brazil, Spain
Biogen
2
Research sites
45
Patients around the world
Requirements for the patient
To 50 Years
All Gender
Medical requirements
Inclusion criteria
Exclusion criteria
Sites
Hospital de Clínicas de Porto Alegre - HCPA/UFRGS
Recruiting
Consult
View site
Rua Ramiro Barcelos, 2350, Av. Protásio Alves, 211 - Santa Cecília, Porto Alegre - RS, 90035-903
View site
Consult
Hospital Universitari i Politecnic La Fe
Recruiting
Consult
View site
46026 Valencia, Spain
View site
Consult
See details
Contact us
Contact us
Study
ASCEND
Sponsor
Biogen
Study type
Interventional
Requirements
To 50 Years
All Gender
Unique study ID
clinicaltrials.gov
NCT05067790
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent